Charlie Gard's parents storm out of court hearing: 'He's not in pain'

LONDON, July 13 (Reuters) - A British judge deciding whether a critically-ill baby should be given experimental treatment in the United States said on Thursday he would reverse a ruling that the child's life support should be turned off if new evidence justified doing so.

The parents of 11-month-old Charlie Gard have been fighting a legal battle to send their son for the experimental therapy, but Britain's courts have refused permission on the grounds it would prolong his suffering without any realistic prospect of it helping.

Charlie suffers from a form of mitochondrial disease, a rare genetic condition causing progressive muscle weakness and brain damage.

RELATED: A look at Charlie Gard's parents

10 PHOTOS
Charlie Gard's parents
See Gallery
Charlie Gard's parents
Chris Gard and Connie Yates, who are battling to take their baby Charlie to the US for treatment against advice from doctors that he should be taken off life support arrive at The High Court in London, Britain April 5, 2017. REUTERS/Eddie Keogh
Chris Gard and Connie Yates, who are battling to take their baby Charlie to the US for treatment against advice from doctors that he should be taken off life support arrive at The High Court in London, Britain April 5, 2017. REUTERS/Eddie Keogh
Chris Gard and Connie Yates, who are battling to take their baby Charlie to the US for treatment against advice from doctors that he should be taken off life support arrive at The High Court in London, Britain April 5, 2017. REUTERS/Eddie Keogh
Chris Gard, who is battling to take his baby Charlie Gard to the US for treatment against advice from doctors that he should be taken off life support arrives at The High Court in London, Britain April 5, 2017. REUTERS/Eddie Keogh
Connie Yates, who is battling to take her baby Charlie Gard to the US for treatment against advice from doctors that he should be taken off life support arrives at The High Court in London, Britain April 5, 2017. REUTERS/Eddie Keogh
LONDON, ENGLAND - APRIL 07: Parents of Charlie Gard, Chris Gard and Connie Yates, walk through the grounds of the Royal Courts of Justice on April 7, 2017 in London, United Kingdom. Their crowdfunding campaign raising money for treatment in the US for their eight month old son, Charlie Gard, reached its target of �1.2million this past weekend. Charlie suffers from a form of mitochondrial disease and is the subject of a dispute over life-support between the Great Ormond Street specialists who are treating him and his parents. (Photo by Dan Kitwood/Getty Images)
LONDON, ENGLAND - APRIL 07: Parents of Charlie Gard, Chris Gard and Connie Yates, walk through the grounds of the Royal Courts of Justice on April 7, 2017 in London, United Kingdom. Their crowdfunding campaign raising money for treatment in the US for their eight month old son, Charlie Gard, reached its target of �1.2million this past weekend. Charlie suffers from a form of mitochondrial disease and is the subject of a dispute over life-support between the Great Ormond Street specialists who are treating him and his parents. (Photo by Dan Kitwood/Getty Images)
LONDON, ENGLAND - APRIL 07: Parents of Charlie Gard, Chris Gard and Connie Yates, walk through the grounds of the Royal Courts of Justice on April 7, 2017 in London, United Kingdom. Their crowdfunding campaign raising money for treatment in the US for their eight month old son, Charlie Gard, reached its target of �1.2million this past weekend. Charlie suffers from a form of mitochondrial disease and is the subject of a dispute over life-support between the Great Ormond Street specialists who are treating him and his parents. (Photo by Dan Kitwood/Getty Images)
LONDON, ENGLAND - APRIL 07: Parents of Charlie Gard, Chris Gard and Connie Yates, walk through the grounds of the Royal Courts of Justice on April 7, 2017 in London, United Kingdom. Their crowdfunding campaign raising money for treatment in the US for their eight month old son, Charlie Gard, reached its target of �1.2million this past weekend. Charlie suffers from a form of mitochondrial disease and is the subject of a dispute over life-support between the Great Ormond Street specialists who are treating him and his parents. (Photo by Dan Kitwood/Getty Images)
HIDE CAPTION
SHOW CAPTION
of
SEE ALL
BACK TO SLIDE

Last week, London's world-renowned Great Ormond Street Hospital for Children, where Charlie is being treated, asked for a new hearing in light of international offers of treatment after U.S. President Donald Trump and the pope brought the case to worldwide attention.

"If there is important new evidence that suggests my decision should be changed then I will change it," judge Nicholas Francis told the hearing at London's High Court.

In a statement issued before the hearing, Connie Yates and Chris Gard said they loved their son "more than life itself." "If he's still fighting, we're still fighting," they said.

However, the couple later stormed angrily out of the hearing after the judge said they had agreed that Charlie's life without any medical improvement was not worth sustaining.

SEE ALSO: Melania Trump in Paris: First lady speaks French with sick children

"We have said he's not suffering, he's not in pain," Yates said.

Francis initially ruled against the parents in April, and his decision was supported by Britain's Court of Appeal and Supreme Court. The European Court of Human Rights also upheld the ruling that a trip to the United States would cause unnecessary suffering.

Lawyers for the parents need to persuade the judge that new evidence has come to light that means he should review his original verdict.

"What I can't do ... is reopen issues that already have been dealt with, not only be me, but by the Court of Appeal," he said.

He told the court he would not give his final decision on Thursday, but said it was important it was given as soon as possible. (Reporting by Michael Holden; Editing by Mark Potter)

Read Full Story

Sign up for Breaking News by AOL to get the latest breaking news alerts and updates delivered straight to your inbox.

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.